ASHG Session: What You Need to Know About the NIH Genomic Data Sharing Policy


This session will give an overview of the NIH Genomic Data Sharing (GDS) Policy that sets forth expectations that ensure the broad and responsible sharing of large-scale human or non-human data. The GDS Policy applies to all NIH-funded research that generates large-scale human or non-human genomic data as well as the use of these data for subsequent research. The ancillary meeting will also provide in-depth understanding of GDS Policy privacy protection when working with human genomic data and navigate attendees through the recent implementation changes to harmonize with the NIH Data Management and Sharing (DMS) Policy (NOT-OD-22-198, NOT-OD-21-013). This is a great opportunity for ASHG attendees to meet experts from NIH and discuss GDS Policy questions.  

Speakers: Cheryl Jacobs, Ph.D., Team Lead, NIH Genomic Data Sharing Policy, Office of Science Policy and Julia Slutsman, Ph.D., Director, NIH Genomic Data Sharing Policy Implementation, Office of Extramural Research.  Website:


There is no cost to attend this event.  However, pre-registration is strongly recommended.  To register for the event, please provide the information below.


For general questions:


Contact: Danyelle Winchester

Novel and Exceptional Technology and Research Advisory Committee Meeting

The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will hold a virtual meeting to discuss the draft report of the Working Group on Data Science and Emerging Technology.  In addition, the meeting will include a discussion of next steps for the Committee (Federal Register notice).

Registration is not required to view the webcast.

The materials below contain content that is not fully supported by assistive technology. For accessibility assistance with these files, please contact:

NIH Videocast


NExTRAC August 29, 2023 Agenda

Meeting Materials

Draft Report of the NExTRAC WG on Data Science and Emerging Technology*

*Note: The NExTRAC working group’s report is a draft, pre-decisional document. The NExTRAC publicly discussed and endorsed the draft findings and recommendations with minor modifications to the report at the August 29, 2023 meeting. The final NExTRAC report was transmitted to the Acting NIH Director and can be found here.

Public Comments

Members of the public may request to make an oral public comment or may submit written public comments. To sign up to make an oral public comment, please submit your name, affiliation, and short description of the oral comment to by August 25, 2023. Once all time slots are filled, only written comments will be accepted.

Any interested person may file written comments by e-mailing by August 25, 2023. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Other than name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your comments. Please note that any comments NIH receives may be posted unredacted to the Office of Science Policy website.

Additional Files

Presentation – Draft Report of the Working Group on Data Science and Emerging Technology
Presentation – ENGAGE Charge to the NExTRAC

NIH Workshop on Catalyzing the Development of Novel Alternatives Methods

The National Institutes of Health (NIH) will hold a virtual workshop on August 21, 2023, on approaches, challenges, and opportunities relating to the development of Novel Alternative Methods (NAMs).  The workshop will also feature discussion on identifying incentives and barriers to successful implementation of NAMs technologies. 



Meeting Agenda

Registration Information

Pre-registration for viewing the workshop is requested.  There is no registration fee associated with this workshop.  For details on how to register, please see:

Supplementary Information

Advisory Committee to the NIH Director Working Group on Catalyzing the Development and Use of Novel Alternative Methods to Advance Biomedical Research                                                                                                                                          

Request for Information (RFI): Catalyzing the Development and Use of Novel Alternative Methods to Advance Biomedical Research (Comments must be received by September 5, 2023)

Workshop on Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer

NIH will host a virtual workshop on July 31, 2023, to discuss policies and practices that shape biomedical innovation and promote access to NIH-funded discoveries. Goals will include discussing how NIH, as a research institution, approaches the patenting and licensing of biomedical inventions.  There will also be discussion on the agency’s role in the broader biomedical research enterprise in promoting the application of knowledge to enhance human health.



Meeting Agenda

Background Information

Background on Patenting and Licensing at NIH

Public Health and Economic Impact Study of NIH Intramural Technology Transfer Licensing

Participant Biographies

Information on Providing Comments

We invite members of the public to submit written comments on the topic of this workshop. For those wishing to make written comments, please submit those comments to by August 18, 2023, so that they may be considered prior to preparing the report of this workshop. The comments we receive may be posted to the OSP website without redaction. As such, please do not include any information in your comments that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should also not be included in your comments.

Public Comments

Compiled Set of Written Comments (June 28 – August 19, 2023)